AVITA Medical, Inc.

NasdaqCM:RCEL 주식 보고서

시가총액: US$350.2m

AVITA Medical 관리

관리 기준 확인 2/4

AVITA Medical CEO는 Jim Corbett, Sep2022 에 임명되었습니다 의 임기는 2.17 년입니다. 총 연간 보상은 $ 2.07M, 30.2% 로 구성됩니다. 30.2% 급여 및 69.8% 보너스(회사 주식 및 옵션 포함). 는 $ 116.01K 가치에 해당하는 회사 주식의 0.033% 직접 소유합니다. 116.01K. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 6.1 년입니다.

주요 정보

Jim Corbett

최고 경영자

US$2.1m

총 보상

CEO 급여 비율30.2%
CEO 임기2.2yrs
CEO 소유권0.03%
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간6.1yrs

최근 관리 업데이트

Recent updates

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Oct 04
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 11
AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Jul 18
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Jun 18
Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

Apr 12
Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

Feb 02
AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Oct 20
The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Avita Medical appoints James Corbett as CEO

Sep 29

AVITA Medical says trial evaluating its RECELL system to treat vitiligo met main goal

Sep 12

Avita's burn therapy Recell gets insurance coverage in Japan following approval

Sep 01

AVITA Medical GAAP EPS of -$0.25 beats by $0.15, revenue of $8.34M beats by $1.18M

Aug 11

AVITA Medical Is Interesting, But Not Just Yet

Dec 21

AVITA Medical reports preliminary Q2 revenue in-line with consensus

Jan 12

AVITA: COVID-19's Impact

Nov 17

CEO 보상 분석

Jim Corbett 의 보수는 AVITA Medical 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$57m

Jun 30 2024n/an/a

-US$50m

Mar 31 2024n/an/a

-US$45m

Dec 31 2023US$2mUS$625k

-US$35m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$31m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$2mUS$157k

-US$27m

Sep 30 2022n/an/a

-US$30m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$256kn/a

-US$25m

보상 대 시장: Jim 의 총 보상 ($USD 2.07M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.14M ).

보상과 수익: 회사가 수익성이 없는 동안 Jim 의 보상이 증가했습니다.

CEO

Jim Corbett (66 yo)

2.2yrs

테뉴어

US$2,068,675

보상

Mr. James M. Corbett, also known as Jim, served as Chief Executive Officer of CathWorks Ltd. since October 27, 2017 until 2021. He serves as Director of CathWorks Ltd.until 2021. He served as an Independe...

리더십 팀

이름위치테뉴어보상소유권
James Corbett
CEO, President & Executive Director2.2yrsUS$2.07m0.033%
$ 116.0k
David O'Toole
Chief Financial Officer1.4yrsUS$2.18m데이터 없음
David Fencil
Senior Vice President of Global Operations1.8yrs데이터 없음데이터 없음
Katie Bush
Senior Vice President of Scientific & Medical Affairsless than a year데이터 없음데이터 없음
Jessica Ekeberg
Investor Relations Executiveno data데이터 없음데이터 없음
Nicole Kelsey
Chief Legal & Compliance Officer and Corporate Secretaryless than a year데이터 없음데이터 없음
Debbie Garner
Senior Vice President of Global Marketing & Strategy6.3yrs데이터 없음데이터 없음
Rob Hall
Senior Vice President of Human Resources1.8yrs데이터 없음데이터 없음
Niraj Doshi
Senior Vice President of Product Development & Program Management1.8yrs데이터 없음데이터 없음
Ron Lagerquist
Senior Vice President of Quality Assurance & Regulatory Affairs1.8yrs데이터 없음데이터 없음
Robin VanDenburgh
Senior Vice President of U.S. Commercial Salesless than a year데이터 없음데이터 없음

1.8yrs

평균 재임 기간

경험이 풍부한 관리: RCEL 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름위치테뉴어보상소유권
James Corbett
CEO, President & Executive Director3.3yrsUS$2.07m0.033%
$ 116.0k
Jan Reed
Independent Non-Executive Director3.3yrsUS$211.12k0.11%
$ 385.8k
Jeremy Curnock-Cook
Independent Non-Executive Director12.1yrsUS$199.87k0.079%
$ 275.2k
Fiona Wood
Founder and Member of Clinical Advisory Board8.8yrsUS$29.80k데이터 없음
Louis Panaccio
Independent Non-Executive Chairman10.3yrsUS$234.69k0.16%
$ 576.4k
Robert McNamara
Independent Non-Executive Director1.6yrsUS$369.11k0.075%
$ 262.1k
Cary Vance
Independent Non-Executive Director1.6yrsUS$364.94k0.037%
$ 128.6k
Suzanne Crowe
Independent Non-Executive Director8.8yrsUS$195.28k0.10%
$ 363.5k

6.1yrs

평균 재임 기간

67yo

평균 연령

경험이 풍부한 이사회: RCEL 의 이사회는 경험(평균 재직 기간 6.1 년)으로 간주됩니다.